Dr. Elana J. Bernstein, MD

Dr. Bernstein practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Bernstein's NPI, 1235334764, was assigned on June 15, 2007. Dr. Bernstein graduated from Icahn School Of Medicine At Mount Sinai in 2007. Dr. Bernstein holds New York license 255959.

Dr. Bernstein's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Bernstein's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Bernstein is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Bernstein to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernstein practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Bernstein's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Bernstein is board certified in internal medicine by the American Board of Internal Medicine. Dr. Bernstein is licensed in New York.

Dmand AI lists lupus among the conditions Dr. Bernstein treats.

CMS data shows 132 Medicare services from Dr. Bernstein across 3 procedure codes in 2024, for 47 Medicare patients. Medicare paid $11,317 for them. Every service was in an office.

CMS counts 47 Medicare patients who saw Dr. Bernstein in 2024. The largest group is 65 to 74, with 21 patients. 68% of them have high blood pressure, and 64% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bernstein's median patient age at 53, with 82% women.

In 2024, Dr. Bernstein wrote 387 Medicare Part D claims for 54 patients. 84% of them were for generic drugs. CMS names the drug for 272 of them, across 12 drugs with 11 or more claims each, at $370,203 in total drug cost. In 2023, CMS named 172 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bernstein for performance year 2024, reported through an alternative payment model (APM). Dr. Bernstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bernstein as offering telehealth.

Dmand AI links 87 papers to Dr. Bernstein, published from 2011 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Lung Diseases, Interstitial, Scleroderma, Systemic and Lung. Dr. Bernstein has published most often in Arthritis Rheumatol. Dr. Bernstein's most frequent co-authors are Shervin Assassi, MD, Tracy Minan Frech, MD and Dinesh Khanna, MD.

Dmand AI links Dr. Bernstein to 7 clinical trials, 5 of them phase 2 studies. Conditions studied include Scleroderma, Systemic, Scleroderma, Diffuse and Livedoid Vasculopathy. Civi Biopharma, Inc. sponsors the most, 2.

CMS Open Payments shows 72 general payments to Dr. Bernstein from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $48,896. It also lists 5 research payments totaling $14,974 from 2023 to 2024.

Dmand AI lists 3 awards for Dr. Bernstein. Dr. Bernstein serves on American College of Rheumatology Annual Meeting Planning Committee.

Dr. Bernstein graduated from Icahn School Of Medicine At Mount Sinai in 2007. Dr. Bernstein is a member of AOA, ACR and MMS.

Dr. Bernstein is in network with 12 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.